Document Detail


The A-allele of the common FTO gene variant rs9939609 complicates weight maintenance in severe obese patients.
MedLine Citation:
PMID:  22310469     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective:The A-allele of the fat mass and obesity-associated (FTO) gene variant rs9939609 has been associated with increased body weight, whereas no effect on weight loss during weight reduction programs has been observed. We questioned whether the AA-genotype interferes with weight stabilization after weight loss.Design:We conducted a monocentric, longitudinal study involving obese individuals. The FTO gene variant rs9939609 was genotyped in participants attending a weight reduction program that was divided into two phases: a weight reduction period with formula diet (12 weeks) and a weight maintenance phase (40 weeks). Body weight, body mass index (BMI), blood pressure and concentrations of blood glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein and triglycerides were determined in week 0 (T(0)), after 12 weeks (T(1)) and at the end in week 52 (T(2)).Subjects:A total of 193 obese subjects aged between 18 and 72 years (129 female, 64 male; initial body weight: 122.4±22.3 kg, initial BMI: 41.8±6.7 kg m(-2)) were included.Results:Genotyping revealed 32.1% TT-, 39.4% AT- and 28.5% AA-genotype carriers. At T (0), carriers of the AA-genotype had significantly higher body weight (P=0.04) and BMI (P=0.005) than carriers of the TT-genotype. Of the 193 participants, 68 discontinued and 125 completed the program. Dropout rate was not influenced by genotype (P=0.33). Completers with AA-genotype showed significantly lower additional weight loss during the weight maintenance phase than TT-genotype carriers (P=0.02). Furthermore, among participants facing weight regain during weight maintenance (n=52), more subjects were carrying the AA-genotype (P=0.006). No influence of genotype on weight reduction under formula diet was observed (P=0.32).Conclusion:In this program, the AA-genotype of rs9939609 was associated with a higher initial body weight and did influence success of weight stabilization. Thus, emphasizing the maintenance phase during a weight reduction program might result in better success for AA-genotype carriers.International Journal of Obesity advance online publication, 7 February 2012; doi:10.1038/ijo.2012.14.
Authors:
A Woehning; J-H Schultz; E Roeder; A Moeltner; B Isermann; P P Nawroth; C Wolfrum; G Rudofsky
Related Documents :
22559919 - Nitrogen content, amino acid composition and digestibility of fungi from a nutritional ...
2858569 - The effect of indoramin on plasma lipids in hypercholesterolemic patas monkeys.
1706019 - Cardiovascular risk factors and health behavior: some preliminary findings from the car...
8049189 - Factor vii coagulant activity and cholesterol changes in premenopausal women consuming ...
19622599 - Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabo...
20515519 - Anti-inflammatory effects of the mediterranean diet: the experience of the predimed study.
19893099 - Insulin resistance and chronic inflammation are associated with muscle wasting in end-s...
20136469 - Gamiwalbitang, composed of four herbs, controls body weight increase and lipid level el...
3772909 - Oral contraceptives and lipoprotein metabolism.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-07
Journal Detail:
Title:  International journal of obesity (2005)     Volume:  -     ISSN:  1476-5497     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256108     Medline TA:  Int J Obes (Lond)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ProxTom Lymphatic Vessel Reporter Mice Reveal Prox1 Expression in the Adrenal Medulla, Megakaryocyte...
Next Document:  Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.